Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by wolfy2424on Jan 09, 2017 3:15am
266 Views
Post# 25681957

RE:Interesting to look back at a 2011 ProMetic slideshow, hype?

RE:Interesting to look back at a 2011 ProMetic slideshow, hype?
Biofinder wrote: https://www.prometic.com/wp-content/uploads/2014/08/129.ProMetic_Jan_12_BioTech_Shocase.pdf

Page 12 shows what the company thought the pps will be. It's interesting to look back at a 2011 slideshow and the Company's hype or belief as to where they thought they were going at that time, and six years later, here we is... finally a BLA filing for plasminogen!  Now all the company has to do is to get the FDA to accept their BLA filing... then get FDA approval... 
 
 


Your post should not be over looked and it's very frustrating to see how 6 years later they are really no further ahead from a revenue perspective - hopefully the short attack woke them up to realize they need to either put up or shut up in the coming 1, 2, 3 years.   How long can they keep up with the 'multiple shots on goal' phrase in their marketing material?

In that 2011 I see alot of fluff and big promises but looking back now how much of it actually happened? 

Instead of multiple shots - take 1 shot and execute it instead of burning through endless cash, diluting the shareholder base and prolonging any actual results








Bullboard Posts